🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In patients with previously untreated Marginal zone lymphoma (MZL), a treat...
Status
Active Not Recruiting
Location
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing,
Start Date
2025-10-01
Trial ID
NCT07480863
Treatments Being Tested
This study aims to evaluate the safety and efficacy of orelabrutinib (O) in...
Status
Recruiting
Location
Changzhou Second People's Hospital
Start Date
2026-07-15
Trial ID
NCT07719556
Treatments Being Tested
This is a prospective single arm phase II study, and the purpose of this st...
Status
Recruiting
Location
China Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences
Start Date
2024-07-11
Trial ID
NCT06513234
Treatments Being Tested
This is a multicenter prospective single arm phase II study, and the purpos...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-06-20
Trial ID
NCT06454968
Treatments Being Tested
This study focuses on treatment-naïve marginal zone lymphoma (MZL) patients...
Status
Recruiting
Location
Beijing Tongren Hospital
Start Date
2025-11-25
Trial ID
NCT07355699
Treatments Being Tested
The aim of this study is to evaluate the efficacy and safety of Glofitamab ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-01
Trial ID
NCT06656221
Treatments Being Tested
This is a multi-center, prospective study. The main purpose is to evaluate ...
Status
Recruiting
Location
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University#Huai'an First People's Hospital#
Start Date
2024-08-25
Trial ID
NCT06566807
Treatments Being Tested
The goal of this clinical trial is to test the overall response rate of Ore...
Status
Recruiting
Location
The Second Affiliated Hospital of Zhejiang University, Ningbo First Hospital
Start Date
2023-01-02
Trial ID
NCT06134284
Treatments Being Tested
This is a multi-center, prospective cohort study. The main purpose of Cohor...
Status
Recruiting
Location
The First Affiliated Hospital ，Zhejiang University School of Medicine
Start Date
2024-06-28
Trial ID
NCT06504940
This study intends to conduct a prospective, multicenter, open-label, rando...
Status
Not Yet Recruiting
Location
Ruijin Hosiptal
Start Date
2026-07
Trial ID
NCT07719855